BEAM – 30-Min Long Trade Setup!📈 🟢
🔹 Asset: Beam Therapeutics Inc. (BEAM – NASDAQ)
🔹 Timeframe: 30-Min Chart
🔹 Setup Type: Ascending Triangle Breakout + Retest
📊 Trade Plan – Long Position
✅ Entry Zone: $17.00 (Breakout confirmation at triangle apex)
✅ Stop-Loss (SL): $15.75 (Below trendline + recent support)
🎯 Take Profit Tar
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−95.44 MXN
−7.85 B MXN
1.32 B MXN
85.36 M
About Beam Therapeutics Inc.
Sector
Industry
CEO
John Evans
Website
Headquarters
Cambridge
Founded
2017
FIGI
BBG0166VGZN0
Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.
BEAM – 30-Min Short Trade Setup!📉
🔹 Ticker: BEAM (NASDAQ)
🔹 Setup: Rising Wedge Breakdown + Resistance Rejection
🔸 Breakdown Price: ~$18.48
📊 Trade Plan (Short Position)
✅ Entry Zone: $18.40–$18.55 (yellow zone rejection)
✅ Stop Loss (SL): Above $19.83 (white resistance zone)
✅ Take Profit Targets:
📌 TP1: $17.14 (red zone – mino
Long Trade Setup Breakdown for (BEAM) - 30!📊 Chart
🔹 Asset: Beam Therapeutics Inc. (BEAM)
🔹 Timeframe: 30-Min Chart
🔹 Setup Type: Symmetrical Triangle Breakout
🚀 Trade Plan (Long Position):
✅ Entry Zone: $32.40 (Breakout Confirmation)
✅ Stop-Loss (SL): $29.56 (Below Support)
🎯 Take Profit Targets (Long Trade):
📌 TP1: $35.64 (First Resistanc
Beam $BEAM Long In the case of Beam Therapeutics ( NASDAQ:BEAM ), the weekly chart displays a promising pattern characterized by a higher low, indicating a potential bottoming process in the stock's price movement. This higher low suggests a reversal of the previous downtrend and potentially signals a shift towards
Cathie Wood is long BEAM, But I will be Strong Short #CathieWood
Baught this stock...I analyzed it....and …...well....I would do exact the opposite......
But why?
Technical Analysis
Let forget eveything you know about technical analysis, and let together tell this story....logically..
At
76-71 USD AGGRESSIVE SELLERS FORCED THE PICE DOWN
29,72
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of BEAM is 310.00 MXN — it hasn't changed in the past 24 hours. Watch BEAM THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange BEAM THERAPEUTICS INC stocks are traded under the ticker BEAM.
BEAM stock has fallen by −34.19% compared to the previous week, the month change is a −39.34% fall, over the last year BEAM THERAPEUTICS INC has showed a −29.39% decrease.
We've gathered analysts' opinions on BEAM THERAPEUTICS INC future price: according to them, BEAM price has a max estimate of 1,618.71 MXN and a min estimate of 404.68 MXN. Watch BEAM chart and read a more detailed BEAM THERAPEUTICS INC stock forecast: see what analysts think of BEAM THERAPEUTICS INC and suggest that you do with its stocks.
BEAM stock is 3.07% volatile and has beta coefficient of 2.08. Track BEAM THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is BEAM THERAPEUTICS INC there?
Today BEAM THERAPEUTICS INC has the market capitalization of 34.14 B, it has decreased by −11.71% over the last week.
Yes, you can track BEAM THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
BEAM THERAPEUTICS INC is going to release the next earnings report on May 13, 2025. Keep track of upcoming events with our Earnings Calendar.
BEAM earnings for the last quarter are −22.73 MXN per share, whereas the estimation was −25.61 MXN resulting in a 11.27% surprise. The estimated earnings for the next quarter are −24.33 MXN per share. See more details about BEAM THERAPEUTICS INC earnings.
BEAM THERAPEUTICS INC revenue for the last quarter amounts to 626.88 M MXN, despite the estimated figure of 358.05 M MXN. In the next quarter, revenue is expected to reach 287.14 M MXN.
BEAM net income for the last quarter is −1.88 B MXN, while the quarter before that showed −1.90 B MXN of net income which accounts for 1.10% change. Track more BEAM THERAPEUTICS INC financial stats to get the full picture.
No, BEAM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has 483 employees. See our rating of the largest employees — is BEAM THERAPEUTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BEAM THERAPEUTICS INC EBITDA is −8.21 B MXN, and current EBITDA margin is −619.73%. See more stats in BEAM THERAPEUTICS INC financial statements.
Like other stocks, BEAM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BEAM THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.